EMOL Health Participates in AVBCC  

EMOL Health Participates in AVBCC  

In October 2024, leadership from EMOL Health was able to attend the Association for Value-Based Cancer Care (AVBCC) Fall Summit, held in New York, NY. EMOL Health President & CEO, Brian Decker, was invited to participate in an important panel discussion on...
EMOL Health Poster Presentation at WCLC  

EMOL Health Poster Presentation at WCLC  

Dr. Ray Page, DO, PhD of the Center for Cancer and Blood Disorders (Texas Cancer Center) was joined by EMOL Health Leadership the 2024 World Conference on Lung Cancer in San Diego. They jointly presented their results from a year long program that was implemented...
IASLC World Conference on Lung Cancer

IASLC World Conference on Lung Cancer

EMOL Health, a data aggregation company for community oncology practices, Ray D. Page, DO, and AstraZeneca announce that their abstract has been accepted for presentation at the 2024 IASLC World Conference on Lung Cancer to be held in San Diego, September 7-10. The...
EMOL Health and ALL4Cure Publish at ASH

EMOL Health and ALL4Cure Publish at ASH

Continuing in their long-term collaboration in data management in multiple myeloma, EMOL is proud to announce the contribution of its Founder & CEO, Brian Decker in the recently published Study Assessing the All4Cure Health Technology Intervention on Patient...
EMOL Health’s Real-World Data in Action

EMOL Health’s Real-World Data in Action

Published in Targeted Oncology (ePub 2023 Nov 1), Trilaciclib Enhances Survival in ES-SCLC,According to Real-World Data, discusses the implications of the findings from data manuallycurated by EMOL Health, in collaboration with Ajeet Gajra, MD, and G1 Therapeutics....